Log in or Sign up for Free to view tailored content for your specialty!
Infectious Diseases News
Risk for myalgic encephalomyelitis/chronic fatigue syndrome no greater after COVID-19
COVID-19 does not increase patients’ risk for developing myalgic encephalomyelitis/chronic fatigue syndrome during the 1-year period post infection, according to a registry study published in JAMA Network Open.
Nasal S. aureus colonization accounts for most postoperative staph infections
Nasal colonization with Staphylococcus aureus accounted for most postoperative staph infections in a large cohort of adults who underwent surgery, according to a study published in Open Forum Infectious Diseases.
Log in or Sign up for Free to view tailored content for your specialty!
Incidence of invasive aspergillosis varies among children with leukemia
Invasive aspergillosis occurs in around 3% to 5% of children with acute leukemia, according to findings published in Journal of the Pediatric Infectious Diseases Society.
COVID-19 vaccine pipeline could bring more changes to ‘menu of options’
Given the nuances of COVID-19 vaccine protection, Kizzmekia Corbett-Helaire, PhD, an assistant professor of immunology and infectious diseases at Harvard's School of Public Health, said the U.S. “should remain diligent in reviewing efficacy and safety data of each COVID-19 vaccine update to make progressional recommendations.”
Top in ID: 'Elevated risk' for eastern equine encephalitis; FDA OKs updated COVID vaccine
Last week a patient in New Hampshire who tested positive for eastern equine encephalitis virus died after being hospitalized with severe central nervous system diseases, according to a press release.
Oropouche virus confirmed in US travelers returning from Cuba
According to a new report, 21 U.S. residents have returned from travel in Cuba this year with Oropouche virus, which is spread through fly or mosquito bites.
FDA grants emergency use authorization to updated COVID vaccine
The FDA granted emergency use authorization for an updated version of the COVID-19 vaccine manufactured by Novavax that targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2 virus.
Should US consider risk-based recommendations for COVID-19 vaccines?
CDC advisors this year introduced the idea of transitioning the United States from a universal recommendation for COVID-19 vaccination to a recommendation based on individual risk factors.
Wegovy linked to fewer COVID-19-related deaths vs. placebo in SELECT population
In an analysis of deaths of patients with obesity but not diabetes from the SELECT trial, those assigned semaglutide 2.4 mg had reduced risk for death from COVID-19 compared with those assigned placebo.
Nondeceptive placebos effective, easy to use for patients with COVID-19-related stress
Placebos administered without deception, or nondeceptive placebos, may offer an alternative and effective way to help people manage prolonged stress, according to a study published in Applied Psychology: Health and Well-Being.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read